Turn Therapeutics (TTRX) Profit After Tax (2024 - 2026)

Turn Therapeutics' quarterly Profit After Tax came in at -$970972.0 in Q1 2026, down 195.54% year-on-year from $1.0 million in Q1 2025, and down 451.9% quarter-over-quarter from $275920.0 in Q4 2025.

Turn Therapeutics has reported Profit After Tax for 3 years, with the latest figure at -$970972.0 in Q1 2026.

  • For the quarter ending Q1 2026, Profit After Tax fell 195.54% year-over-year to -$970972.0; the trailing twelve-month figure through Mar 2026 stood at -$2.9 million (changed N/A YoY), and the FY2025 full-year result was -$3.2 million, down 80.62% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$970972.0, down from $275920.0 in the prior quarter.
  • The five-year high for Profit After Tax was $275920.0 in Q4 2025, with the low at -$1.9 million in Q3 2025.
  • Average Profit After Tax over 3 years is -$652892.5, with a median of -$497494.5 recorded in 2024.
  • Year-over-year, Profit After Tax soared 185.39% in 2025 and tumbled 195.54% in 2026.
  • Tracing TTRX's Profit After Tax over 3 years: stood at -$323130.0 in 2024, then soared by 185.39% to $275920.0 in 2025, then plunged by 451.9% to -$970972.0 in 2026.
  • The last three Profit After Tax figures came in at -$970972.0 (Q1 2026), $275920.0 (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.99 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 30.90 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.03 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.63 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 727.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 205.99 Mn
10 Turn Therapeutics 188.06 Mn 188.06 Mn - -970,972.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -970,972.00
Dec 31, 2025 275,920.00
Sep 30, 2025 -1.90 Mn
Mar 31, 2025 -328,547.00
Dec 31, 2024 -323,130.00
Sep 30, 2024 -666,442.00